CN115902071A - Method for detecting fat-soluble vitamins in sample - Google Patents
Method for detecting fat-soluble vitamins in sample Download PDFInfo
- Publication number
- CN115902071A CN115902071A CN202310189805.4A CN202310189805A CN115902071A CN 115902071 A CN115902071 A CN 115902071A CN 202310189805 A CN202310189805 A CN 202310189805A CN 115902071 A CN115902071 A CN 115902071A
- Authority
- CN
- China
- Prior art keywords
- sample
- magnetic beads
- vitamin
- polymer
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 72
- 229940088594 vitamin Drugs 0.000 title claims abstract description 63
- 229930003231 vitamin Natural products 0.000 title claims abstract description 63
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 63
- 239000011782 vitamin Substances 0.000 title claims abstract description 63
- 239000011324 bead Substances 0.000 claims abstract description 126
- 229920000642 polymer Polymers 0.000 claims abstract description 68
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 60
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 27
- 238000001514 detection method Methods 0.000 claims abstract description 23
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 28
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 18
- 229940045997 vitamin a Drugs 0.000 claims description 18
- 239000012491 analyte Substances 0.000 claims description 17
- 210000002966 serum Anatomy 0.000 claims description 16
- 229930003427 Vitamin E Natural products 0.000 claims description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 14
- 239000011709 vitamin E Substances 0.000 claims description 14
- 235000019165 vitamin E Nutrition 0.000 claims description 14
- 229940046009 vitamin E Drugs 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 229930003448 Vitamin K Natural products 0.000 claims description 11
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 11
- 239000011712 vitamin K Substances 0.000 claims description 11
- 235000019168 vitamin K Nutrition 0.000 claims description 11
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 11
- 229940046010 vitamin k Drugs 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- -1 alkyl modified silica gel Chemical class 0.000 claims description 8
- 239000003480 eluent Substances 0.000 claims description 8
- 229920001600 hydrophobic polymer Polymers 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 230000004913 activation Effects 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 5
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 5
- 210000000941 bile Anatomy 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 210000003722 extracellular fluid Anatomy 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 claims description 4
- 239000013558 reference substance Substances 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 210000001138 tear Anatomy 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 239000012620 biological material Substances 0.000 claims description 2
- 230000002496 gastric effect Effects 0.000 claims description 2
- 230000001926 lymphatic effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 10
- 238000004811 liquid chromatography Methods 0.000 abstract description 8
- 239000000523 sample Substances 0.000 description 86
- 239000007788 liquid Substances 0.000 description 20
- 239000003153 chemical reaction reagent Substances 0.000 description 15
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 13
- 239000004793 Polystyrene Substances 0.000 description 13
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 13
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 13
- 239000011772 phylloquinone Substances 0.000 description 13
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 13
- 239000011719 vitamin A Substances 0.000 description 13
- 235000019155 vitamin A Nutrition 0.000 description 13
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 11
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 239000012224 working solution Substances 0.000 description 11
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 10
- 238000012546 transfer Methods 0.000 description 10
- KJKIIUAXZGLUND-ICCVIKJNSA-N 25-hydroxyvitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@H](C)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C KJKIIUAXZGLUND-ICCVIKJNSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- 229930003316 Vitamin D Natural products 0.000 description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 235000019166 vitamin D Nutrition 0.000 description 6
- 239000011710 vitamin D Substances 0.000 description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 description 6
- 229940046008 vitamin d Drugs 0.000 description 6
- 239000000945 filler Substances 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 230000006920 protein precipitation Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- JWUBBDSIWDLEOM-XHQRYOPUSA-N (3e)-3-[(2e)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2\C1=C\C=C1/CC(O)CCC1=C JWUBBDSIWDLEOM-XHQRYOPUSA-N 0.000 description 4
- 235000021318 Calcifediol Nutrition 0.000 description 4
- BGPVFRJUHWVFKM-UHFFFAOYSA-N N1=C2C=CC=CC2=[N+]([O-])C1(CC1)CCC21N=C1C=CC=CC1=[N+]2[O-] Chemical compound N1=C2C=CC=CC2=[N+]([O-])C1(CC1)CCC21N=C1C=CC=CC1=[N+]2[O-] BGPVFRJUHWVFKM-UHFFFAOYSA-N 0.000 description 4
- 238000011067 equilibration Methods 0.000 description 4
- 239000006249 magnetic particle Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000000622 liquid--liquid extraction Methods 0.000 description 3
- 239000000696 magnetic material Substances 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 125000005504 styryl group Chemical group 0.000 description 3
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 210000004880 lymph fluid Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000002552 multiple reaction monitoring Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- FCKJYANJHNLEEP-XRWYNYHCSA-N (24R)-24,25-dihydroxycalciol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CC[C@@H](O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C FCKJYANJHNLEEP-XRWYNYHCSA-N 0.000 description 1
- GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 description 1
- MBWXNTAXLNYFJB-VKXGTQFMSA-N 5,6,7,8-tetradeuterio-2-[(e)-3,7,11,15-tetramethylhexadec-2-enyl]-3-(trideuteriomethyl)naphthalene-1,4-dione Chemical compound O=C1C(C([2H])([2H])[2H])=C(C\C=C(/C)CCCC(C)CCCC(C)CCCC(C)C)C(=O)C2=C([2H])C([2H])=C([2H])C([2H])=C21 MBWXNTAXLNYFJB-VKXGTQFMSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical group C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000007825 activation reagent Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- SVWLIIFHXFGESG-UHFFFAOYSA-N formic acid;methanol Chemical compound OC.OC=O SVWLIIFHXFGESG-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FPLYNRPOIZEADP-UHFFFAOYSA-N octylsilane Chemical compound CCCCCCCC[SiH3] FPLYNRPOIZEADP-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
Abstract
The present invention provides a method for the detection of a fat-soluble vitamin in a sample, said method comprising the step of contacting a polymer, in particular a styrene-based polymer coated magnetic bead, with the sample. The method can be used in sample preparation and pretreatment of mass spectrometry and liquid chromatography. The invention also provides application of the magnetic beads in detection of fat-soluble vitamins in a sample and a kit for detecting the fat-soluble vitamins in the sample.
Description
Technical Field
The invention belongs to the field of biology, and particularly relates to a method for detecting fat-soluble vitamins in a sample.
Background
Fat-soluble vitamins meanVitamins which are soluble in water and soluble in fatty organic solvents include, for example, vitamin A, vitamin D, vitamin E and vitamin K, where vitamin D includes, for example, vitamin D 2 And vitamin D 3 . Fat-soluble vitamins have diverse effects, and besides being directly involved in and influencing specific metabolic processes, they also bind to intracellular nuclear receptors to influence the expression of specific genes. The fat-soluble vitamins play an important role in the growth, metabolism and development process of human bodies. The reasonable vitamin level is very important for maintaining the health of human body, the content of fat-soluble vitamin in the human body is accurately measured, people can be guided to scientifically and reasonably supplement vitamin, diseases are prevented, the life quality is improved, and meanwhile, the method has auxiliary diagnosis significance for clinical judgment, treatment management and physiological evaluation of deficiency or excess of fat-soluble vitamin. The determination of fat-soluble vitamins is an important task in clinical samples.
At present, when fat-soluble vitamins in a sample are clinically measured, because the components of the clinical sample are complex and cannot be directly detected, the sample needs to be pretreated firstly, so that the sample can possibly enter a subsequent analysis procedure after being properly separated and purified. The pretreatment methods of fat-soluble vitamins adopted in the prior art comprise Protein Precipitation (PPT), liquid-liquid extraction (LLE), solid-phase extraction (SPE) and the like. However, the pretreatment method in the prior art has the defect that automation cannot be realized and/or effective detection of the fat-soluble vitamin A, D, E, K cannot be realized at the same time.
CN113376270B discloses a pretreatment method for detecting protein precipitation of a sample of fat-soluble vitamins in serum by high performance liquid chromatography tandem mass spectrometry, which comprises the step of treatment by adopting a negative pressure device. The method is simple to operate, but because the protein precipitation is actually used for diluting the sample, the concentration of the substance to be detected in the on-machine sample is low, and the requirement on the sensitivity of a measuring instrument is high; moreover, the method requires negative pressure operation, which is not favorable for realizing full automation of the operation process. CN110779780A discloses a sample pretreatment method for detecting fat-soluble vitamins in serum by high performance liquid chromatography tandem mass spectrometry, which uses ethanol for protein precipitation, and uses n-hexane for liquid-liquid extraction, nitrogen for drying extraction liquid, and sample redissolution to carry out sample injection analysis. The method involves the steps of extraction, nitrogen blowing and the like in the experimental process, needs a large amount of manual operation and is not beneficial to the automation of treatment; and the operation process is complicated, and the requirement on experimenters is high. CN111198238A discloses a method for extracting and detecting vitamin D in serum, which comprises the steps of firstly carrying out protein precipitation on a sample, then loading a precipitated mixed solution onto an active carbon 96-well plate, eluting by using strong volatile reagents such as n-hexane and the like, carrying out re-dissolution on the sample after the eluent is dried by nitrogen, and then selectively adsorbing a target substance by using a solid-phase extraction method. However, in the experiment, the solid phase extraction filler can generate swelling phenomenon after contacting with the organic reagent, the flow rate of the solution passing through the solid phase extraction filler can be influenced, so that the problem of poor uniformity among pores is generated, and the processing of drying the nitrogen by blowing is not beneficial to the processing automation. CN114487209a discloses a method for detecting liposoluble vitamin a, vitamin D and vitamin E in serum by using a magnetic solid-phase extraction material, which utilizes an external magnetic field and a magnetic solid-phase extraction filler (hydrophilic-lipophilic balance type magnetic solid-phase extraction magnetic beads, HLB magnetic beads), however, the method has low sensitivity for detecting vitamin a and cannot detect vitamin K.
Therefore, the existing methods can not realize sensitive, effective and/or automatic detection of the fat-soluble vitamin A, D, E, K in the sample. Clinical testing objectively requires providing a method that overcomes at least one of the problems of the prior art described above, and in particular is effective in detecting fat-soluble vitamins; and preferably further automation of the detection can be achieved.
Disclosure of Invention
The inventor of the invention finds that the detection of a plurality of fat-soluble vitamins can be realized by contacting a sample with polymer-coated magnetic beads (especially hydrophobic polymer magnetic beads), the high detection sensitivity is realized, and the simultaneous detection of a plurality of fat-soluble vitamins including vitamin K can be further realized.
Based on this finding, in a first aspect of the present invention, a method for detecting a target analyte in a sample is provided, comprising the step of contacting polymer-coated magnetic beads to the sample, wherein the target analyte is preferably a fat-soluble vitamin.
The magnetic bead of the invention is a magnetic particle, which has a magnetic core and a coating material coated on the surface of the magnetic core, wherein the coating material is a polymer material, especially a hydrophobic polymer, such as alkyl modified silica gel or a styrene-based polymer, the alkyl modified silica gel is, for example, C18 or C8 alkyl modified silica gel, and the styrene-based polymer is, for example, styrene-divinylbenzene copolymer.
The magnetic beads preferably have an appropriate particle size, for example, an average particle size of 1 to 200. Mu.m, for example, 10 to 100. Mu.m, or 30 to 50. Mu.m.
In the present invention, the "sample" means a product form from which the component to be detected is derived. Herein, the sample may refer to a biological sample, e.g. a clinical sample, which is preferably selected from the group consisting of whole blood, plasma, serum, urine, saliva, tears, bile, gastric fluid, interstitial fluid and lymphatic fluid.
In the invention, the magnetic bead has a magnetic core and a polymer coated on the surface of the magnetic core. The polymer may be a styrene-based polymer. The styrene-based polymer refers to a polymer formed by polymerizing styrene as a main monomer, or referred to as a styrene-based polymer. The styrene-based polymer herein may be polystyrene formed with styrene as the only monomer, or may be a polymer formed by adding other crosslinking agents (e.g., divinylbenzene), such as styrene-divinylbenzene copolymer. The polymers may be formed by different processes (e.g., fluidized bed processes, reaction kettle processes) and may have different degrees of crosslinking.
In the present invention, the magnetic core of the magnetic bead comprises magnetic particles, which may consist of any substance having magnetic properties, preferably selected from oxides of iron, cobalt, nickel, more preferably ferroferric oxide. As known in the art, the magnetic core may be prepared using any suitable method.
The inventors have further found in their research that the movement and/or separation of the sample can be further achieved by the action of the applied magnetic field. For example, the magnetic field is applied to realize rapid and sufficient transfer of the sample, particularly liquid (including solution or suspension), and simultaneously, the problems of blocking a chromatographic column caused by residues in the transfer process of the magnetic material can be avoided. Based on this finding, automated manipulation of moving and/or separating a sample under an applied magnetic field can be achieved.
Accordingly, in the method of the present invention, a step of moving and/or separating the sample under application of a magnetic field is further included. More specifically, the step of applying the magnetic field to move and/or separate the sample is performed by placing a magnet on the outside of the wall of the container containing the sample such that the sample is attracted to the inside of the wall of the container when the magnetic field is applied, or by placing a magnet on the bottom of the container, thereby transferring the sample on the machine, and achieving the problem of no magnetic beads remaining in the sample on the machine.
In some embodiments, the moving and/or separating the sample is performed by removing the sample from a container holding the sample and the magnetic beads, or by removing the magnetic beads from a container holding the sample and the magnetic beads.
In some embodiments, the step of moving and/or separating the sample under application of the magnetic field may be accomplished by placing a magnet outside the sidewall of the container containing the sample such that the sample is drawn onto the container sidewall when the magnetic field is applied, or by inserting a magnet into the container containing the sample and removing the magnet.
The magnet may be a permanent magnet or an electromagnet, preferably an electromagnet, which may be conveniently switched on and off to control the presence and absence of the magnetic field. In the case of an electromagnet, the on-off of the electromagnet can be controlled by a Programmable Logic Controller (PLC) so as to meet the full-automatic requirement of sample processing.
In a particular operation, the magnet may be placed or inserted into a solution or suspension containing the sample.
In one embodiment, the step of moving and/or separating the sample under the application of the magnetic field is achieved by placing a magnet outside the sidewall of the container containing the sample, such that the sample is attracted to the container sidewall when the magnetic field is applied. In a more specific embodiment, the magnet may be present in two positions: a side suction position and a bottom suction position. For magnets in a side-draw position, the magnet is located outside the sidewall of the container holding the solution or suspension of the sample, such that when a magnetic field is applied (e.g., by turning on the power supply of an electromagnet or moving a permanent magnet) the sample is drawn onto the container sidewall; for a magnet in a bottom-attractive position, the magnet is positioned below the bottom wall of a container holding a solution or suspension of the sample, such that when a magnetic field is applied (e.g., by turning on the power supply of an electromagnet or moving a permanent magnet) the sample is attracted to the bottom wall of the container. In some embodiments, there may be only magnets in side attraction; in other embodiments, only magnets in the bottom attraction position may be present; in other embodiments, both magnets in the side-attracting and bottom-attracting positions may be present.
The position and/or the on-off state of the magnet are switched to be matched with the operation of transferring liquid (solution or suspension), so that the automatic operation of transferring liquid between different containers can be effectively realized.
In addition, the present invention may better achieve adequate transfer of liquid by a "side-attracting" magnet for moving and/or separating a sample under an applied magnetic field by placing the magnet outside the sidewall of a container holding a solution or suspension of the sample such that the sample is attracted to the container sidewall when the magnetic field is applied. Compared with the bottom suction position design that the magnet is positioned below the bottom wall of the container, the side suction magnet can effectively avoid the defects of liquid loss (insufficient bottom liquid suction) caused by a bottom suction position magnetic field and the defects that the magnetic material is remained and blocks a chromatographic column and the like caused by the fact that the magnetic material is sucked away, and has convenient transfer operation and automation realization.
Based on the above findings, the method of the present invention further comprises the step of moving and/or separating the sample under the applied magnetic field. Further, the step of moving and/or separating the sample under the applied magnetic field is achieved by placing a magnet outside the sidewall of the container holding the solution or suspension of the sample, such that the sample is attracted to the container sidewall when the magnetic field is applied, or by inserting the magnet into the solution or suspension holding the sample and removing the magnet.
In the method of the invention, the container may be a multi-well plate such as a 2-well plate, a 4-well plate, a 6-well plate, a 12-well plate, a 24-well plate, a 48-well plate, or a 96-well plate, or a separate tube.
In the method of the present invention, the following steps may be included:
a) Contacting the magnetic beads with the sample to adsorb target analytes in the sample;
b) Applying a magnetic field to separate the magnetic beads having the target analyte adsorbed thereon from the non-adsorbed sample components;
c) The magnetic beads having the target analyte adsorbed thereon are brought into contact with an eluent, so that the target analyte is allowed to pass from the magnetic beads into the eluent.
In some embodiments of the invention, there is further included a step of further activating and equilibrating the magnetic beads prior to step a, and/or a step of washing the magnetic beads having the target analyte adsorbed thereon after step b) and prior to step c), wherein the washing allows removal of non-specifically adsorbed components other than the target analyte from the magnetic beads while retaining or substantially retaining the target analyte still adsorbed on the magnetic beads.
In some embodiments of the invention, the moving and/or separating of the sample in the method is achieved by aspirating a liquid (or fluid) in one container and releasing the liquid (or fluid) in another container.
In some embodiments of the invention, the container is a multi-well plate or a separate tube; for example, 2-well plates, 12-well plates, 24-well plates, 48-well plates, 96-well plates, etc.; the container may have a U-shaped or V-shaped bottom shape.
In some embodiments of the present invention, the organic solvent for activation is selected from the group consisting of methanol, ethanol, acetonitrile, isopropanol, and a combination thereof, the organic solvent for equilibration is a mixed solvent of water and an organic solvent selected from the group consisting of methanol, ethanol, acetonitrile, and isopropanol, and the solvent for rinsing is water or a mixed solvent of water and an organic solvent selected from the group consisting of methanol, ethanol, acetonitrile, and isopropanol; the solvent for elution is selected from acetonitrile, methanol, ethanol, isopropanol and any combination thereof, or any combination of water and acetonitrile, methanol, ethanol or isopropanol. Preferably, the washing reagents used for washing include a weak washing reagent which may contain 80% to 100% water and a strong washing reagent which may contain 60% to 90% water.
In the method of the present invention, the transfer of the sample between different containers can be achieved by moving the pipetting needle up and down in the container. Preferably, the base of the pipetting needle is provided with an elastic element, so that the pipetting needle can elastically retract when moving downwards to contact the bottom of the container; preferably, the pipetting needle base is provided with an adjustment structure such that the stop position of the pipetting needle tip can be adjusted as close as possible to the bottom of the container without damaging the pipetting needle and/or the container.
In the method of the present invention, the method further comprises the steps of:
the polymer-treated sample is analyzed using an analytical method selected from the group consisting of mass spectrometry and liquid chromatography, including combinations thereof, such as liquid chromatography-mass spectrometry (LC-MS) and liquid chromatography tandem mass spectrometry (LC-MS/MS).
In another aspect of the present invention, there is provided a use of polymer-coated magnetic beads (e.g., styrene-based polymer-coated magnetic beads) for detecting a lipid-soluble vitamin in a sample. More specifically, the fat-soluble vitamins are detected using mass spectrometry or liquid chromatography.
In another aspect of the present invention, there is further provided a fat-soluble vitamin detection kit or kit comprising polymer-coated magnetic beads (e.g., styrene-based polymer-coated magnetic beads) and optionally a fat-soluble vitamin as a reference substance. Specifically, the kit is used for detecting the fat-soluble vitamin by mass spectrometry or liquid chromatography. More specifically, the kit further comprises an eluent and optionally a eluent. In some embodiments, the kit or kit is for performing a method according to the invention.
The present inventors have found that the magnetic beads (including PS magnetic beads, HLB magnetic beads, C18 magnetic beads, and C8 magnetic beads) used in the present invention can be effectively used for detecting fat-soluble vitamins. Especially hydrophobic polymer magnetic beads (such as styrene-based polymer magnetic beads and C8 or C18 magnetic beads), and 5 common fat-soluble vitamins (vitamin A and vitamin D) 2 Vitamin D 3 Vitamin E and vitamin K 1 ) Has good grasping and adsorbing effects, especially on vitamin K (such as vitamin K) 1 ) The detection of (2) is also significantly superior to other types of magnetic beads.
Description of the terms
The terms "magnetic bead", "magnetic particle" and "magnetic particle" are used interchangeably herein to refer to a particle that is magnetically charged.
As used herein, "polymer" refers to a macromolecular compound that may have a relative molecular mass ranging from several thousand to several million and may be a mixture of many homologs with different relative molecular masses.
Herein, the "hydrophobic polymer" refers to a polymer in which the surface (including the inner pore surface) of a magnetic bead formed of the polymer is hydrophobic, such as a styrene-based polymer and an alkyl-modified silica gel polymer, and more specifically, the alkyl-modified silica gel polymer is, for example, a C8 or C18 alkyl-modified silica gel polymer. Magnetic beads coated with a hydrophobic polymer are referred to herein as hydrophobic polymer magnetic beads, such as styrene-based polymer magnetic beads, alkyl-modified silica gel polymer magnetic beads (particularly C18 or C8 alkyl-modified silica gel polymer magnetic beads, also referred to herein as C18 or C8 silica gel magnetic beads, or C18 or C8 magnetic beads).
Herein, "styrene-based polymer" means a polymer formed by polymerizing styrene as a main monomer, and may also be referred to as "styrenic polymer". The styrene-based polymer herein may be polystyrene formed with styrene as the only monomer, or a polymer formed by adding other crosslinking agents (e.g., divinylbenzene), such as styrene-divinylbenzene copolymer. The polymers may be formed by different processes (e.g., fluidized bed processes, reaction vessel processes) and may have different degrees of crosslinking. In this context, the styrene-divinylbenzene copolymer refers to a polymer formed by polymerizing styrene and divinylbenzene as monomers, and particularly includes a copolymer formed by using styrene as a monomer and divinylbenzene as a crosslinking agent.
Herein, "styrene-based polymer magnetic beads" means magnetic beads coated with a styrene-based polymer, for example, polystyrene magnetic beads (PS magnetic beads) means magnetic beads coated with a polystyrene polymer, particularly, a polymer formed by crosslinking styrene and divinylbenzene. In addition, when a magnetic bead of a styrene-based polymer is mentioned herein, it means that the benzene ring of the polymer has no modification group (particularly, hydrophilic modification group).
As used herein, "HLB magnetic beads" are a specific type of polymer-coated magnetic beads, also known as hydrophilic-lipophilic balance magnetic beads. The polymer may further contain a hydrophilic group on the basis of the lipophilic styrene-based skeleton, and a typical hydrophilic group may have an N-vinylpyrrolidone structure, and may also have a structure such as a carboxyl group, a sulfonic acid group, an amine group, and the like. By a suitable ratio of lipophilic structures to hydrophilic groups, a balance of hydrophilic and lipophilic properties within a certain range is achieved.
Herein, "C18 magnetic beads" and "C8 magnetic beads" as specific types of polymer-coated magnetic beads refer to magnetic beads having a silica gel material as a framework and a coated magnetic core modified by a C18 or C8 alkyl group, for example, octadecyl silica gel polymeric magnetic beads, i.e., C18 magnetic beads, can be obtained by octadecyl trichlorosilane bonding, and octyl silane polymeric magnetic beads, i.e., C8 magnetic beads, can be obtained by octane trichlorosilane bonding.
Herein, "contacting a magnetic bead with a sample" means exposing the sample to the magnetic bead such that an interaction occurs.
Herein, fat-soluble vitamins refer to a class of vitamins insoluble in water and soluble in fats and non-polar organic solvents (e.g., benzene, ether, chloroform, etc.), including vitamin A, D, E, K, etc. Vitamin D is cyclopentane polyhydrophenanthrene compound belonging to sterols, including vitamin D 2 And vitamin D 3 Also includes its active metabolismForms such as 25-hydroxyvitamin D 3 25-hydroxy vitamin D 2 1, 25-dihydroxyvitamin D 3 24, 25-dihydroxyvitamin D 3 And so on. The vitamin K includes naturally occurring vitamin K 1 And K 2 And the like.
Herein, when referring to the detection of a fat-soluble vitamin, one or more of said fat-soluble vitamins may be detected as target analyte simultaneously, said fat-soluble vitamins being selected from vitamin a, vitamin D 2 Vitamin D 3 Vitamin E, vitamin K 1 And vitamin K 2 Preferably two or more of said fat-soluble vitamins are detected simultaneously. In a specific embodiment wherein only one of said fat-soluble vitamins is detected, said fat-soluble vitamin is preferably vitamin K (e.g. vitamin K) 1 And/or K 2 ). In a specific embodiment wherein two or more of the fat-soluble vitamins are detected simultaneously, the fat-soluble vitamins preferably comprise at least vitamin K (e.g. vitamin K) 1 And/or K 2 ) In particular the fat-soluble vitamins may also include vitamin a, vitamin D 2 Vitamin D 3 Vitamin E, vitamin K 1 And vitamin K 2 Or any combination thereof.
Herein, the particle size means the average particle size of the particle population. The particle size measurement method includes a sieving method, a microscopic method, a sedimentation method, a resistance method, and the like.
As used herein, "liquid chromatography" refers to chromatography using a liquid as the mobile phase, which may have a stationary phase in a variety of forms. "mass spectrometry" refers to a method of detecting ions (charged atoms, molecules or molecular fragments, molecular ions, isotopic ions, fragment ions, rearranged ions, multiply charged ions, metastable ions, negative ions, ions generated by ion-molecule interactions, etc.) that move by separating them according to their mass-to-charge ratios using an electric field and a magnetic field. Liquid chromatography or mass spectrometry herein also includes combinations or combinations thereof, such as liquid chromatography-mass spectrometry (LC-MS) and liquid chromatography tandem mass spectrometry (LC-MS/MS), and the like.
In this context, the term "selected from" means that it may be an option listed thereafter, or a combination of one or more of them.
In this context, the purpose of "activation" is to create an environment compatible with the sample solvent and to remove impurities from the container; the purpose of "equilibration" is on the one hand to remove the organic solvent remaining upon activation and on the other hand to facilitate the acceptance of a sample with water as the main solvent, corresponding to a switch of the solvent system; "washing" means an operation for washing away interfering components adsorbed on the magnetic beads but retaining target molecules. Accordingly, "activator," "equilibrating agent," and "rinse" refer to the agents, particularly solvents and solvent combinations, required to accomplish the above-described activation, equilibration, and rinsing operations.
Herein, "retaining the target analyte still adsorbed on the magnetic bead" means that a majority of the target analyte still remains adsorbed on the magnetic bead, e.g. at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or even at least 98% of the target analyte still is adsorbed on the magnetic bead.
Herein, "sample" refers to an object to be tested, and may be a biological sample, such as a clinical sample, including whole blood, plasma, serum, urine, saliva, tears, bile, gastric juice, interstitial fluid, lymph fluid, etc., and may be a biological material selected from the group consisting of whole blood, plasma, serum, urine, saliva, tears, bile, gastric juice, interstitial fluid, and lymph fluid, and the sample may be any combination of the above samples. The sample may be in liquid or fluid form, or even in solid form. Samples in solid form may optionally be tested after treatment such as homogenization.
Drawings
Figure 1 is a schematic view of the magnet of the present invention in a side-attracted position,
fig. 2 is a schematic view of the magnet of the present invention in a bottom attracted position.
In fig. 1, the magnet 4 is located at the outer side of the side wall of the container 1 (plate well), the sample solution or suspension 2 is in the container 1, and the magnetic beads 3 are gathered and fixed at the side wall of the container 1 under the action of the external magnetic field of the magnet 4 in the side attraction position, so that the transfer operation of the solution or suspension 2 is not affected, and the liquid in the container 1 can be ensured to be sufficiently sucked out.
In fig. 2, the magnet 4 is positioned below the bottom wall of the container 1 (well) and the sample solution or suspension 2 is present in the container 1. The sample solution or suspension 2 in the container 1 can be agitated or shaken while the magnet 4 is in the bottom attraction position.
Detailed Description
In the following examples, unless otherwise specified, the reagents and instruments used are those commonly used in the art and are available from chemical or biological products/preparations; the procedures used in the following examples are conventional in the art, and the procedures of these experiments can be unambiguously known and the corresponding results obtained by those skilled in the art according to the prior art or the operation manual provided by the manufacturer.
Examples
Example 1.
The standard substances, main reagent sources and instrument models used in the present invention are shown in the following table.
TABLE 1 details of sources of standard substances
Name of standard substance | Brand |
Vitamin A-d5 | Toronto Research Chemicals |
25-hydroxy vitamin D 2 -d6 | Toronto Research Chemicals |
25-hydroxy vitamin D 3 -d6 | Medical Isotopes |
Vitamin E-d6 | Sigma-Aldrich |
Vitamin K-d7 | Sigma-Aldrich |
Vitamin A | Sigma Alrdich |
25-hydroxy vitamin D 2 | Toronto research chemistry canada |
25-hydroxy vitamin D 3 | Toronto research chemistry TRC of canada |
Vitamin E | Sigma Alrdich |
Vitamin K 1 | Sigma-Aldrich |
TABLE 2 details of the sources of the main reagents
Name of reagent | Brand |
Bovine serum albumin | Thermo Fisher |
High purity water | Watsons water |
Formic acid | Fisher |
Methanol | Fisher chemical |
Acetonitrile | Fisher chemical |
TABLE 3 Instrument make and model
Name of instrument | Brand | Model number |
Liquid chromatography tandem mass spectrometer | Aiboceisi Limited | AB SCIEX Triple Quad TM 4500MD |
The PS beads (polystyrene beads) and HLB beads (hydrophilic lipophilic balance beads) used in the examples herein were prepared according to the method described in CN111250067 a. Specifically, PS beads were prepared according to CN111250067a example 2, HLB beads were prepared according to CN111250067a example 3, and C18 beads/C8 beads (octadecyl polymeric beads/n-octyl polymeric beads) were prepared according to CN 113559830A example 1.
1. Preparation of test solutions
a. Preparation of mixed standard working solution
5 kinds of vitamin A and 25-hydroxy vitamin D are prepared 2 25-hydroxy vitamin D 3 Vitamin E and vitamin K 1 The mixed standard working solution is ready for use. The stock solution concentrations used and the formulated mixed standard working solution concentrations are shown in table 4 below.
TABLE 4 preparation of the Mixed Standard working solutions
Compound (I) | Stock solution concentration (μ g/mL) | Volume removal (mu L) | Mixed standard working solution (mu g/mL) |
Vitamin A | 100 | 200 | 20 |
25-hydroxy vitamin D 2 | 10 | 50 | 0.5 |
25-hydroxy vitamin D 3 | 10 | 200 | 2 |
Vitamin E | 1000 | 300 | 300 |
Vitamin K 1 | 1 | 200 | 0.2 |
Methanol | - | 50 |
b. Preparation of spiked serum samples
Taking a 9 mL human serum sample, adding 1 mL standard-mixing working solution, mixing for 2min to obtain standard-adding serum sample (vitamin A:2.0 μ g/mL; 25-hydroxy vitamin D) 2 0.05 mu g/mL; 25-hydroxy vitamin D 3 0.2 mu g/mL; vitamin E is 30 mug/mL; vitamin K 1 :0.02 μg/mL)。
c. Preparation of working solution with 5 kinds of vitamin internal standards
5 vitamins, namely vitamin A and 25-hydroxy vitamin D, are taken out of a refrigerator at 20 ℃ below zero 2 25-hydroxy vitamin D 3 Vitamin E and vitamin K 1 The single standard internal standard stock solution is unfrozen at room temperature, and internal standard working solution is prepared according to the table 5 after uniform mixing for later use.
Table 5 internal standard working liquid preparing table
Compound (I) | Stock solution concentration (μ g/mL) | Volume removal (mu L) | Internal standard working solution (mu g/mL) |
Vitamin A-d5 | 100 | 200 | 2 |
25-hydroxy vitamin D 2 -d6 | 10 | 50 | 0.05 |
25-hydroxy vitamin D 3 -d6 | 10 | 200 | 0.2 |
Vitamin E-d6 | 1000 | 300 | 30 |
Vitamin K 1- d7 | 1 | 200 | 0.02 |
80% methanol | - | 9050 | - |
d. Sample pretreatment
Magnetic bead activation: adding 2 mg magnetic solid phase extraction filler (PS magnetic beads, HLB magnetic beads, C18 magnetic beads or C8 magnetic beads) into 400 μ L methanol for activation, shaking at the bottom suction position for 0.5 min, transferring the 96-well plate to the side suction position, standing for 0.5 min, and transferring the activation reagent in the 96-well plate to a waste liquid tank by a liquid transfer system.
Magnetic bead balancing: transferring 400 mu L of water by a liquid transfer system to perform magnetic solid phase extraction and filler balance; oscillating for 0.5 min at the bottom suction position, transferring the 96-well plate to the side suction position, and standing for 0.5 min; the pipetting system transfers the equilibration reagents in the 96-well plate to a waste reservoir.
Internal standard and sample addition: transferring 400 mu L of internal standard working solution by a liquid transfer system, then adding 400 mu L of sample, and oscillating for 5 min at a bottom suction position; the side-draw position was stationary for 1 min and the pipetting system transferred the sample reagents in the 96-well plate to the waste reservoir.
Leaching 1: transferring 400 mu L of pure water by a liquid transferring system, and oscillating for 1 min at a bottom suction position; the side-draw station was allowed to stand for 1 min and the pipetting system transferred the rinse 1 reagents in the 96-well plate to the waste reservoir.
Leaching 2: transferring 400 mu L of 20% acetonitrile by a liquid transferring system, and oscillating for 1 min at a bottom suction position; the side-draw position was stationary for 1 min and the pipetting system transferred the reagents for elution 2 from the 96-well plate to the waste reservoir.
Elution is carried out: transferring 100 mu L of acetonitrile by a liquid transferring system, and oscillating for 2min at a bottom suction position; the side draw station was allowed to stand for 2min and the pipetting system transferred the eluted reagents from the 96 well plate to a 96 well V plate. Waiting for the detection on the computer.
e. HPLC-MS analysis
1) Liquid chromatography detection conditions: a chromatographic column: an octadecyl packed chromatography column (2.1 mm X50 mm,1.7 μm, 130A);
mobile phase: phase A is 0.1% formic acid water solution, and phase B is 0.1% formic acid methanol solution;
gradient elution procedure: 0-0.2min, 80% by weight B; 0.2-2.0min, 98% of (B); 2.0-4.8min,98% b; 4.8-4.9 min,80% by weight B; 4.9-6.0min, 80% by weight of (B);
flow rate: 0.4 mL/min;
sample introduction amount: 10. mu L;
column temperature: 45. is at one hundred percent
2) Mass spectrum conditions:
an ion source: atmospheric Pressure Chemical Ionization (APCI); the detection mode is as follows: multiple Reaction Monitoring (MRM); air curtain gas (CUR): 35 psi, atomizing gas (GS 1): 40 psi, temperature (TEM): 400. c, collision gas (CAD): 8 psi. Mass spectral parameters of parent ion, daughter ion, residence time, cone hole voltage, collision energy, etc. for each compound are shown in table 6 below.
TABLE 6 Mass Spectrometry parameters for the Compounds
Compound (I) | Q1 | Q3 | DP | EP | CE | CXP |
Vitamin A | 269.1 | 93.1 | 140 | 8 | 50 | 8 |
Vitamin A-d5 | 274.1 | 93.1 | 40 | 8 | 21 | 8 |
25-hydroxy vitamin D 2 | 395.3 | 269.4 | 78 | 9 | 24 | 20 |
25-hydroxy vitamin D 2 -d6 | 401.2 | 269.3 | 130 | 10 | 24 | 5 |
25-hydroxy vitamin D 3 | 383.4 | 229.2 | 60 | 10 | 28 | 20 |
25-hydroxy vitamin D 3 -d6 | 389.4 | 229.2 | 81 | 13 | 35 | 20 |
Vitamin E | 431 | 165.2 | 180 | 7 | 35 | 12 |
Vitamin E-d6 | 437.3 | 171.2 | 140 | 10 | 35 | 26 |
Vitamin K 1 | 451.4 | 187.1 | 60 | 8 | 36 | 10 |
Vitamin K-d7 | 458.3 | 194.2 | 95 | 13 | 36 | 19 |
f. The result of the detection
After being eluted, styryl polymer magnetic beads, hydrophilic-lipophilic balance magnetic beads, C18 magnetic beads and C8 magnetic beads are connected with a mass spectrometer for mass spectrometry, and the results are shown in Table 7.
TABLE 7 response results of various types of magnetic bead signals
Detection object | HLB magnetic bead Signal | PS bead signal | C18 magnetic bead signal | C8 magnetic bead signal |
Vitamin A | 3.05×10 6 | 2.91×10 6 | 1.45×10 6 | 1.03×10 6 |
25-hydroxy vitamin D 2 | 3.21×10 5 | 1.04×10 6 | 6.93×10 5 | 8.89×10 5 |
25-hydroxy vitamin D 3 | 3.34×10 5 | 1.23×10 6 | 7.11×10 5 | 1.76×10 5 |
Vitamin E | 2.21×10 6 | 5.58×10 6 | 1.40×10 6 | 5.59×10 5 |
Vitamin K 1 | 1.52×10 3 | 2.93×10 6 | 7.33×10 5 | 1.24×10 6 |
As can be seen from the above experimental results, the magnetic beads of the present invention can be used for detecting fat-soluble vitamins. Especially PS magnetic beads, C18 magnetic beads and C8 magnetic beads, for 5 fat-soluble vitamins (vitamin A, 25-hydroxyvitamin D) 2 25-hydroxy vitamin D 3 Vitamin E and vitamin K 1 ) Has good grabbing and adsorbing effects, especially on vitamin K 1 The detection of (2) is also significantly better than other types of magnetic beads, of which PS beads perform the most excellent.
Example 2: styrene based Polymer magnetic bead Performance inspection
The standard, primary reagent, and magnetic bead sources were the same as in example 1.
The embodiment provides a liquid chromatography tandem mass spectrometry detection method of fat-soluble vitamins based on magnetic solid phase extraction, which comprises the following steps:
1. sample preparation
1.1 The internal standard working solution was prepared as in example 1.
1.2 Repetitive sample preparation
The method comprises the steps of taking 10 real serum samples, taking 1 mL from each real serum sample, mixing the samples together to prepare a 10 mL real serum sample, repeatedly measuring the sample 15 times, and inspecting the repeatability of the method.
1.3 Accuracy sample preparation
Taking out the sample of the reference substance from the refrigerator, thawing for standby, and ensuring that the measured value is within the required range of the quality control product.
2. Sample pretreatment and HPLC-MS were the same as in example 1.
3. Results of the experiment
3.1 Repeatability of
Samples of known concentration 2-3 were tested in parallel at least 10 times and the Coefficient of Variation (CV) should be no greater than 15.0%.
The experimental result shows that: in the determination method for capturing and enriching the fat-soluble vitamins in the serum by the styryl polymer magnetic beads, the repeatability meets the requirement of clinical detection.
3.2 Accuracy of
The detection is carried out using as a sample a reference substance (standard substance) which can be used for evaluating a conventional method, and the measurement result thereof should be within a concentration range allowed for the standard substance.
The experimental result shows that: in the determination method for capturing and enriching the fat-soluble vitamins in the serum by the styryl polymer magnetic beads, the accuracy meets the requirement of clinical detection.
Claims (26)
1. A method of detecting a target analyte in a sample, comprising the step of contacting polymer-coated magnetic beads to the sample, wherein the target analyte is a lipid-soluble vitamin.
2. The method of claim 1, wherein the polymer is a hydrophobic polymer.
3. The method of claim 1 or 2, wherein the polymer is an alkyl modified silica gel polymer or a styrene based polymer.
4. The method according to claim 3, wherein the alkyl modified silica gel polymer is a C18 or C8 alkyl modified silica gel polymer and/or the styrene based polymer is a styrene-divinylbenzene copolymer.
5. The method according to claim 1 or 2, wherein the magnetic beads have an average particle diameter of 1 to 200 μm, 10 to 100 μm, or 30 to 50 μm.
6. The method of claim 1 or 2, wherein the sample is or comprises a biological material selected from the group consisting of whole blood, plasma, serum, urine, saliva, tears, bile, gastric fluid, interstitial fluid and lymphatic fluid.
7. The method of claim 1 or 2, further comprising the step of applying a magnetic field to move and/or separate the sample.
8. The method of claim 7, wherein the step of applying the magnetic field to move and/or separate the sample is accomplished by placing a magnet on the outside of the wall of the vessel containing the sample such that the sample is attracted to the inside of the wall of the vessel when the magnetic field is applied, or by inserting a magnet into the vessel containing the sample and removing the magnet.
9. The method of claim 8, wherein the applied magnetic field is generated by a permanent magnet or an electromagnet.
10. The method of claim 7, wherein the moving and/or separating of the sample is performed by removing the sample from a container containing the sample and the magnetic beads, or by removing the magnetic beads from a container containing the sample and the magnetic beads.
11. The method of claim 8, wherein the container is a multi-well plate or a separate tube.
12. The method according to claim 1 or 2, comprising the steps of:
a) Contacting the magnetic beads with the sample to adsorb target analytes in the sample;
b) Applying a magnetic field to separate the magnetic beads having the target analyte adsorbed thereon from the non-adsorbed sample components;
c) The magnetic beads having the target analyte adsorbed thereon are brought into contact with an eluent, so that the target analyte is allowed to pass from the magnetic beads into the eluent.
13. The method of claim 12, further comprising the step of activating and equilibrating the magnetic beads prior to step a), and/or the step of washing the magnetic beads having target analytes adsorbed thereon after step b) and prior to step c), wherein the washing allows removal of non-specific adsorbed components other than the target analytes from the magnetic beads while leaving the target analytes adsorbed on the magnetic beads.
14. The method of claim 12, wherein the elution uses an eluent selected from the group consisting of: acetonitrile, methanol, ethanol, isopropanol, and any combination thereof, or any combination of water and acetonitrile, methanol, ethanol, or isopropanol.
15. The method of claim 13, wherein the activation uses an activating agent selected from the group consisting of: methanol, ethanol, acetonitrile, isopropanol, and combinations thereof, the rinsing using a rinsing agent selected from the group consisting of: water or a mixed solvent of water and an organic solvent selected from the group consisting of methanol, ethanol, acetonitrile and isopropanol.
16. The method according to claim 1 or 2, further comprising the steps of:
analyzing the polymer-treated sample using an analytical method selected from the group consisting of mass spectrometry, liquid chromatography-mass spectrometry (LC-MS), and liquid chromatography-tandem mass spectrometry (LC-MS/MS).
17. The method of claim 1 or 2, wherein the fat soluble vitamin is or comprises vitamin K.
18. The method of claim 17, wherein the fat soluble vitamins further comprise a vitamin selected from the group consisting of vitamin a, vitamin D 2 Vitamin D 3 And vitamin E, or any combination thereof.
19. A fat-soluble vitamin detection kit comprises polymer-coated magnetic beads.
20. The kit of claim 19, wherein the polymer-coated magnetic beads are hydrophobic polymer-coated magnetic beads.
21. The kit of claim 19, wherein the polymer-coated magnetic beads are styrene-based polymer-coated magnetic beads or alkyl-modified silica gel polymer magnetic beads.
22. The kit of claim 19, further comprising a fat soluble vitamin as a reference substance.
23. The kit of claim 19, wherein the kit is for carrying out the method of claim 1 or 2.
24. Use of polymer-coated magnetic beads for the detection of fat-soluble vitamins.
25. The use of claim 24, wherein the polymer-coated magnetic beads are styrene-based polymer-coated magnetic beads.
26. Use according to claim 24, wherein the fat-soluble vitamin is detected using the method according to claim 1 or 2.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310189805.4A CN115902071A (en) | 2023-02-23 | 2023-02-23 | Method for detecting fat-soluble vitamins in sample |
CN202310714992.3A CN116754677A (en) | 2023-02-23 | 2023-06-15 | Method for detecting fat-soluble vitamins in sample |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310189805.4A CN115902071A (en) | 2023-02-23 | 2023-02-23 | Method for detecting fat-soluble vitamins in sample |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115902071A true CN115902071A (en) | 2023-04-04 |
Family
ID=86473068
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310189805.4A Pending CN115902071A (en) | 2023-02-23 | 2023-02-23 | Method for detecting fat-soluble vitamins in sample |
CN202310714992.3A Pending CN116754677A (en) | 2023-02-23 | 2023-06-15 | Method for detecting fat-soluble vitamins in sample |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310714992.3A Pending CN116754677A (en) | 2023-02-23 | 2023-06-15 | Method for detecting fat-soluble vitamins in sample |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN115902071A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050009002A1 (en) * | 2001-03-20 | 2005-01-13 | Depu Chen | Processes for producing coated magnetic microparticles and uses thereof |
US20090090855A1 (en) * | 2007-06-14 | 2009-04-09 | Uwe Kobold | Preparation of samples for lc-ms/ms using magnetic particles |
US20140033805A1 (en) * | 2012-07-13 | 2014-02-06 | Waters Technologies Corporation | Methods of extracting fat soluble vitamins |
DE102014005993A1 (en) * | 2014-04-28 | 2015-10-29 | Magnamedics Gmbh | Method for enriching trace components from a liquid biological sample |
CN110542735A (en) * | 2019-09-12 | 2019-12-06 | 贝知(上海)医疗科技有限公司 | method for high-throughput determination of multiple fat-soluble vitamins by ultra-high performance liquid mass spectrometry |
CN112067388A (en) * | 2020-09-07 | 2020-12-11 | 苏州英芮诚生化科技有限公司 | High-throughput detection pretreatment method and kit for fat-soluble vitamins in blood plasma |
CN114487209A (en) * | 2022-03-08 | 2022-05-13 | 天津国科医工科技发展有限公司 | Liquid chromatography tandem mass spectrometry detection method of fat-soluble vitamins based on magnetic solid phase extraction |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ232238A (en) * | 1989-02-16 | 1991-07-26 | Wrigley W M Jun Co | Food products containing porous polymeric beads impregnated with a vitamin |
EP2239582A1 (en) * | 2009-04-09 | 2010-10-13 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Assay system for determining binding to hydrophobic drugs |
-
2023
- 2023-02-23 CN CN202310189805.4A patent/CN115902071A/en active Pending
- 2023-06-15 CN CN202310714992.3A patent/CN116754677A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050009002A1 (en) * | 2001-03-20 | 2005-01-13 | Depu Chen | Processes for producing coated magnetic microparticles and uses thereof |
US20090090855A1 (en) * | 2007-06-14 | 2009-04-09 | Uwe Kobold | Preparation of samples for lc-ms/ms using magnetic particles |
US20140033805A1 (en) * | 2012-07-13 | 2014-02-06 | Waters Technologies Corporation | Methods of extracting fat soluble vitamins |
DE102014005993A1 (en) * | 2014-04-28 | 2015-10-29 | Magnamedics Gmbh | Method for enriching trace components from a liquid biological sample |
CN110542735A (en) * | 2019-09-12 | 2019-12-06 | 贝知(上海)医疗科技有限公司 | method for high-throughput determination of multiple fat-soluble vitamins by ultra-high performance liquid mass spectrometry |
CN112067388A (en) * | 2020-09-07 | 2020-12-11 | 苏州英芮诚生化科技有限公司 | High-throughput detection pretreatment method and kit for fat-soluble vitamins in blood plasma |
CN114487209A (en) * | 2022-03-08 | 2022-05-13 | 天津国科医工科技发展有限公司 | Liquid chromatography tandem mass spectrometry detection method of fat-soluble vitamins based on magnetic solid phase extraction |
Non-Patent Citations (4)
Title |
---|
HU CF 等: "Development of magnetic octadecylsilaneparticles as solid-phase extraction adsorbentfor the determination of fat-soluble vitaminsin fruit juice-milk beverage by capillary liquidchromatography" * |
卢山 等: "自动化磁珠法标本制备联合液相色谱串联质谱检测人血清中25-羟基维生素D的性能评价" * |
孙学文 等: "超高效液相色谱-串联质谱法同时测定特殊医学用途配方食品中5种脂溶性维生素" * |
牛之瑞 等: "反高效液相法多波长同时测定营养强化食品中7脂溶性维生素" * |
Also Published As
Publication number | Publication date |
---|---|
CN116754677A (en) | 2023-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7815803B2 (en) | Preparation of samples for LC-MS/MS using magnetic particles | |
CN109406687B (en) | Method for detecting double phospholipids at high flux | |
Li et al. | Basic sample preparation techniques in LC‐MS bioanalysis: protein precipitation, liquid–liquid extraction, and solid‐phase extraction | |
CN114019069A (en) | Pretreatment reagent for detecting small molecular substances in biological sample | |
US10281474B2 (en) | Method for analyzing samples of biological fluid and apparatus for performing the same | |
Shen et al. | Evaluation of automated micro solid phase extraction tips (μ-SPE) for the validation of a LC–MS/MS bioanalytical method | |
CN113009036A (en) | Kit for detecting sex hormone, sex hormone sample pretreatment method and method for simultaneously detecting multiple sex hormones | |
CN115902071A (en) | Method for detecting fat-soluble vitamins in sample | |
CN109828051B (en) | Method for detecting toxic compound | |
CN116399971A (en) | Catecholamine metabolite extraction and detection kit and detection method | |
CN107561184B (en) | Method for detecting coumarin compound in children toy | |
EP2015074A1 (en) | Preparation of samples for LC-MS/MS using magnetic particles | |
US20210333290A1 (en) | High speed sample workflow for lc-ms based hba1c measurement | |
CN117368380B (en) | Kit and method for detecting steroid hormone | |
Schedler et al. | Evaluation of an Automated Sample Preparation System for Analysis of Methacrylates in Saliva | |
US20230273217A1 (en) | Derivatization of at least one analyte of interest for mass spec measurements in patient samples | |
CN112946153A (en) | Method for simultaneously determining multiple pollutants in plastic barreled vegetable oil | |
CN113330314A (en) | Automated sample workflow for LC-MS based HbA1c measurement with respect to intact protein levels | |
WO2023041571A1 (en) | Method for determining at least one analyte of interest | |
CN112246221A (en) | Polyion liquid covalent organic framework material, preparation method and application thereof | |
CN115047111B (en) | Application of magnetic liposome in enrichment of tetrahydrocannabinol and application method | |
Wells | Sample preparation for mass spectrometry | |
Jork et al. | Bioanalytical applications: solid-phase extraction | |
WO2022268803A1 (en) | Method for detecting at least one analyte in a sample | |
CN114073941A (en) | Organic-inorganic hybrid material and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20230404 |